Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer

Identifying actionable components in castration–resistant prostate cancer (CRPC) is critical for the development of effective treatments. Here, the authors show that the inhibition of the redox-protective protein TRX1 decreases the growth of CRPC cells through the regulation of ROS levels, p53 and a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Govindi J. Samaranayake, Clara I. Troccoli, Mai Huynh, Rolando D. Z. Lyles, Karen Kage, Andrew Win, Vishalakshi Lakshmanan, Deukwoo Kwon, Yuguang Ban, Steven Xi Chen, Enrique Rodriguez Zarco, Merce Jorda, Kerry L. Burnstein, Priyamvada Rai
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/d2ca0dbfe1e54bac82aeb4b72d117967
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d2ca0dbfe1e54bac82aeb4b72d117967
record_format dspace
spelling oai:doaj.org-article:d2ca0dbfe1e54bac82aeb4b72d1179672021-12-02T15:37:00ZThioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer10.1038/s41467-017-01269-x2041-1723https://doaj.org/article/d2ca0dbfe1e54bac82aeb4b72d1179672017-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-01269-xhttps://doaj.org/toc/2041-1723Identifying actionable components in castration–resistant prostate cancer (CRPC) is critical for the development of effective treatments. Here, the authors show that the inhibition of the redox-protective protein TRX1 decreases the growth of CRPC cells through the regulation of ROS levels, p53 and androgen receptor expression.Govindi J. SamaranayakeClara I. TroccoliMai HuynhRolando D. Z. LylesKaren KageAndrew WinVishalakshi LakshmananDeukwoo KwonYuguang BanSteven Xi ChenEnrique Rodriguez ZarcoMerce JordaKerry L. BurnsteinPriyamvada RaiNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Govindi J. Samaranayake
Clara I. Troccoli
Mai Huynh
Rolando D. Z. Lyles
Karen Kage
Andrew Win
Vishalakshi Lakshmanan
Deukwoo Kwon
Yuguang Ban
Steven Xi Chen
Enrique Rodriguez Zarco
Merce Jorda
Kerry L. Burnstein
Priyamvada Rai
Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
description Identifying actionable components in castration–resistant prostate cancer (CRPC) is critical for the development of effective treatments. Here, the authors show that the inhibition of the redox-protective protein TRX1 decreases the growth of CRPC cells through the regulation of ROS levels, p53 and androgen receptor expression.
format article
author Govindi J. Samaranayake
Clara I. Troccoli
Mai Huynh
Rolando D. Z. Lyles
Karen Kage
Andrew Win
Vishalakshi Lakshmanan
Deukwoo Kwon
Yuguang Ban
Steven Xi Chen
Enrique Rodriguez Zarco
Merce Jorda
Kerry L. Burnstein
Priyamvada Rai
author_facet Govindi J. Samaranayake
Clara I. Troccoli
Mai Huynh
Rolando D. Z. Lyles
Karen Kage
Andrew Win
Vishalakshi Lakshmanan
Deukwoo Kwon
Yuguang Ban
Steven Xi Chen
Enrique Rodriguez Zarco
Merce Jorda
Kerry L. Burnstein
Priyamvada Rai
author_sort Govindi J. Samaranayake
title Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
title_short Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
title_full Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
title_fullStr Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
title_full_unstemmed Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
title_sort thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/d2ca0dbfe1e54bac82aeb4b72d117967
work_keys_str_mv AT govindijsamaranayake thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT claraitroccoli thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT maihuynh thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT rolandodzlyles thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT karenkage thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT andrewwin thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT vishalakshilakshmanan thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT deukwookwon thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT yuguangban thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT stevenxichen thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT enriquerodriguezzarco thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT mercejorda thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT kerrylburnstein thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
AT priyamvadarai thioredoxin1protectsagainstandrogenreceptorinducedredoxvulnerabilityincastrationresistantprostatecancer
_version_ 1718386318603452416